Description: Emergency contraceptive pill with ulipristal acetate (UPA).

Product Details

User: Female

Hormonal: Yes

Delivery Method: Oral

Duration Type: Emergency

Duration: Single use

  • Single tablet taken up to 5 days after unprotected intercourse

Dose: 30 mg

Active Pharmaceutical Ingredient (API):
  • ulipristal acetate

Multipurpose Preventive Technology (MPT): No

Status Details

Developer: HRA Pharma

Project Phase: Limited Market Availability

Development Stage: SRA/WHO PQ Approved

Active Development: Yes

Status Details:
  • ellaOne was approved for use throughout the European Union by the European Medicines Agency (EMA) in 2009. Approved by the US FDA in 2010.
  • Product is marketed in over 60 countries.

Additional Information


Vertical Tabs